Up next

Autoplay

Dr. Moul Discusses the Long-Term Tolerability and Efficacy of Degarelix

1 Views • 08/29/25
Share
Side Effects
Side Effects
Subscribers
0

Judd W. Moul, MD, director, Duke Prostate Center, James H. Semans, MD, Professor of Surgery, Duke University Medical Center, discusses the 5-year results from a phase III extension trial with a 1-arm crossover from leuprolide to degarelix.

Show more
0 Comments sort Sort By

Up next

Autoplay